HTCRHeartCore Enterprises, Inc.(HTCR)Stock Analysis

AI analysis on 2,800+ stocks →
TechnologyNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1892322HTCR stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $30.4M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

HTCR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for HeartCore Enterprises, Inc. (HTCR), a Technology sector company. HTCR is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $30.4m in revenue. Based on the latest XBRL financial filings (Q1 2026), HeartCore Enterprises, Inc. reports quarterly revenue of $1.2M, net income of $-1.9M, free cash flow of $-1.2M. Top institutional holders of HTCR by reported 13-F value include Board of Trustees of The Leland Stanford Junior University, XTX Topco Ltd, JANE STREET GROUP,, based on the most recent SEC filings. HTCR trades on the Nasdaq exchange and files with the SEC under CIK 1892322. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HTCR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HeartCore Enterprises, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$1.2M

Net Income

Q1 2026

$-1.9M

Free Cash Flow

Q1 2026

$-1.2M

D/E Ratio

Q1 2026

0.09

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-70.5% YoY
$9.0MFY 2025
FY22 $8.8MFY23 $21.8MFY24 $30.4MFY25 $9.0M

Net Income

+491.1% YoY
$5.8MFY 2025
FY22 $-6.7MFY23 $-4.2MFY24 $-1.5MFY25 $5.8M

Operating Income

-1830.2% YoY
$-3.1MFY 2025
FY22 $-6.7MFY23 $-4.1MFY24 $-161.7KFY25 $-3.1M

EPS (Diluted)

+414.3% YoY
$0.22FY 2025
FY22 $-0.37FY23 $-0.21FY24 $-0.07FY25 $0.22

Total Assets

-6.5% YoY
$13.1MFY 2025
FY22 $12.1MFY23 $19.6MFY24 $14.0MFY25 $13.1M

Total Debt

-6.3% YoY
$624.6KFY 2025
FY22 $2.5MFY23 $2.2MFY24 $666.5KFY25 $624.6K

Op. Cash Flow

FY 2025
FY22 $-4.8MFY23 $-4.3MFY24 $-4.8MFY25

AI Insight: HTCR Financial Trends

HeartCore is unprofitably volatile with revenue collapsing to $1M in Q1 2026, offsetting earlier Q3 2024 strength.

Revenue crashed 80% from Q3 2024 peak of $18M to $1M in Q1 2026, with only one profitable quarter (Q3 2024: $11M net income).

Debt reduced from $3M (Q2 2024) to $1M (Q3 2025–Q1 2026), while equity recovered to $7M by Q1 2026 vs. $2M low.

Operating cash flow negative every reported quarter (ranging −$1M to −$2M), signaling chronic operational strain.

Q1 2026 shows renewed losses (−$2M net income, −$2M operating income) after Q4 2025 profitability; trend reversal critical.

Operating CF data gaps in Q3 2025 and Q4 2025–Q1 2026 obscure current cash generation health.

AI Insight: HTCR Ratio Trends

HeartCore collapsed to deeply negative profitability in Q1 2026, with operating margin at −123.6% and ROIC at −82.4%, reversing modest recovery seen in Q2 2025.

Operating margin swung from +2.3% in Q2 2025 to −123.6% in Q1 2026, signaling severe operational distress and near-total margin compression.

Net profit margin deteriorated to −150.2% in Q1 2026 from +23.2% in Q2 2025, indicating losses now exceed revenue.

ROIC collapsed to −82.4% in Q1 2026 from +6.4% in Q2 2025, destroying shareholder value at an accelerating pace.

Q1 2026 marks the third consecutive quarter of negative ROIC; TTM ROIC is −45.7%, indicating systemic profitability failure.

Debt-to-equity improved to 0.09 in Q1 2026 from 0.39 in Q2 2025, but balance-sheet strength is irrelevant amid operating collapse.

Get alerted when HTCR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HeartCore Enterprises, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put HTCR on your watchlist

Track score changes the day HeartCore Enterprises, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HTCR a good stock to buy?

13F Pro's AI-powered analysis of HeartCore Enterprises, Inc. (HTCR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HTCR are available on the HTCR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own HTCR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HTCR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HeartCore Enterprises, Inc.'s investment landscape.